Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer
Chemoresection With 4 Weekly Intravesical Instillations Of Mitomycin C Versus Transurethral Resection (TUR) Followed By One Single Immediate Instillation Of Mitomycin C In Single, Small, Papillary Stage Ta, T1 Bladder Tumors: A Prospective Randomized Phase III Trial
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Terminated
low accrual
Other terminated trials from European Organisation for Research and Treatment of Cancer - EORTC
- Medulloblastoma · Phase PHASE2 · Sep 2025
- Malignant Pleural Mesothelioma · Phase PHASE2 · Jan 2024
- Advanced Soft-tissue Sarcoma · Phase PHASE3 · Nov 2023
- Breast Cancer · Oct 2023
- Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) · Phase PHASE2 · Apr 2023
See all terminations from European Organisation for Research and Treatment of Cancer - EORTC
Other Bladder Cancer trials with similar outcome
Listed as NCT00042887, this PHASE3 trial focuses on Bladder Cancer and remains terminated or withdrawn. Sponsored by European Organisation for Research and Treatment of Cancer - EORTC, it has been updated 6 times since 2002, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
May 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Organisation for Research and Treatment of Cancer - EORTC
For direct contact, visit the study record on ClinicalTrials.gov .